tech
April 14, 2026
Anthropic’s Long-Term Benefit Trust Appoints Vas Narasimhan to Board of Directors
Vas Narasimhan has been appointed to Anthropic's Board of Directors by the Anthropic Long-Term Benefit Trust. He is a physician-scientist and the Chief Executive Officer of Novartis—one of the world's leading innovative medicines companies—and shares Anthropic’s conviction that healthcare and life sciences are among the areas where AI has the greatest potential to improve the quality of human life.
TL;DR
- Vas Narasimhan, CEO of Novartis, has been appointed to Anthropic's Board of Directors.
- The appointment was made by the Anthropic Long-Term Benefit Trust.
- Narasimhan is a physician-scientist with experience in developing and approving novel medicines.
- His expertise is seen as valuable for scaling powerful new technology safely, a key focus for Anthropic.
- Trust-appointed directors now form a majority on Anthropic's board, aiming to balance financial goals with the company's public benefit mission.
- Narasimhan believes AI has significant potential in healthcare and life sciences.
- He has a background in global health initiatives and holds positions on other prominent boards.
Continue reading the original article